Zobrazeno 1 - 10
of 697
pro vyhledávání: '"Jeong Heo"'
Autor:
So Young Yoo, Jeong Heo
Publikováno v:
Molecular Therapy: Oncolytics, Vol 31, Iss , Pp 100732- (2023)
Externí odkaz:
https://doaj.org/article/6f2ae95c53b849f38cb022b9bd8817c2
Autor:
Jeong Heo, Yoon Jun Kim, Sung Wook Lee, Youn-Jae Lee, Ki Tae Yoon, Kwan Soo Byun, Yong Jin Jung, Won Young Tak, Sook-Hyang Jeong, Kyung Min Kwon, Vithika Suri, Peiwen Wu, Byoung Kuk Jang, Byung Seok Lee, Ju-Yeon Cho, Jeong Won Jang, Soo Hyun Yang, Seung Woon Paik, Hyung Joon Kim, Jung Hyun Kwon, Neung Hwa Park, Ju Hyun Kim, In Hee Kim, Sang Hoon Ahn, Young-Suk Lim
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 4, Pp 504-513 (2023)
Background/Aims Despite the availability of direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection in Korea, need remains for pangenotypic regimens that can be used in the presence of hepatic impairment, comorbidities, or prior
Externí odkaz:
https://doaj.org/article/95d31ece645e44a2ae4df56674553d45
Autor:
Sang Youn Hwang, Hyun Young Woo, Jeong Heo, Hyung Jun Kim, Young Joo Park, Ki Youn Yi, Yu Rim Lee, Soo Young Park, Woo Jin Chung, Byoung Kuk Jang, Won Young Tak
Publikováno v:
Cancers, Vol 16, Iss 4, p 838 (2024)
Real-world data regarding treatment with atezolizumab plus bevacizumab in high-risk patients with advanced HCC are lacking. In this multicenter retrospective cohort study, a total of 215 patients with advanced HCC received atezolizumab plus bevacizum
Externí odkaz:
https://doaj.org/article/64cad7c92ca143648a2c28d160bd9f0c
Publikováno v:
Journal of Yeungnam Medical Science, Vol 39, Iss 3, Pp 256-261 (2022)
Sarcoidosis often involves the liver. However, primary hepatic sarcoidosis confined to the liver without evidence of systemic involvement is rare. We report the case of a 37-year-old man with hepatic sarcoidosis who initially presented with elevated
Externí odkaz:
https://doaj.org/article/424c9937077b4bfd87f95c503760e8b2
Autor:
Ghassan K. Abou-Alfa, Peter R. Galle, Yee Chao, Joseph Erinjeri, Jeong Heo, Mitesh J. Borad, Angelo Luca, James Burke, Adina Pelusio, Delphine Agathon, Monika Lusky, Caroline Breitbach, Shukui Qin, Edward Gane
Publikováno v:
Liver Cancer, Pp 1-1 (2023)
Introduction Intratumoral administration of pexa-vec (Pexastimogene Devacirepvec), an oncolytic and immunotherapeutic vaccinia virus. given to patients with hepatocellular carcinoma (HCC), is associated with both local and distant tumor responses. We
Externí odkaz:
https://doaj.org/article/bdd152f1ab754f309e25b0ec1686e9ea
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 17, Iss 1, Pp 1-14 (2022)
Abstract Background The study aim was to report the treatment outcomes of trochanteric flip osteotomy (TFO) with surgical hip dislocation (SHD) for femoral head fracture and dislocation (FHFD) and to investigate the risk factors for avascular necrosi
Externí odkaz:
https://doaj.org/article/b592f534f1894077884cc8298d6cde39
Autor:
Jeong Heo, Yoon Jun Kim, Jin-Woo Lee, Ji Hoon Kim, Young-Suk Lim, Kwang-Hyub Han, Sook-Hyang Jeong, Mong Cho, Ki Tae Yoon, Si Hyun Bae, Eric D. Crown, Linda M. Fredrick, Negar Niki Alami, Armen Asatryan, Do Hyun Kim, Seung Woon Paik, Youn-Jae Lee
Publikováno v:
Gut and Liver, Vol 15, Iss 6, Pp 895-903 (2021)
Background/Aims: Glecaprevir/pibrentasvir (G/P) is the first pan-genotypic direct-acting antiviral combination therapy approved in Korea. An integrated analysis of five phase II and III trials was conducted to evaluate the efficacy and safety of G/P
Externí odkaz:
https://doaj.org/article/5090ec51a94c495aa641491335e33b4f
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 7, p 6495 (2023)
This systematic review aimed to assess the prognostic significance of programmed cell death-ligand 1 (PDL-1) and programmed cell death protein 1 (PD-1) in hepatocellular carcinoma (HCC). Medline, EMBASE, and Cochrane Library database searches were co
Externí odkaz:
https://doaj.org/article/74f7391330b8464d990675afe7521ecb
Autor:
Young Joo Park, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Young Mi Hong, Ki Tae Yoon, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho
Publikováno v:
Gut and Liver, Vol 15, Iss 3, Pp 440-450 (2021)
Background/Aims: Glecaprevir/pibrentasvir (G/P) is a combination of direct-acting antiviral agents that is an approved treatment for chronic infections by all six hepatitis C virus (HCV) genotypes. However, there are limited data on the effect of G/P
Externí odkaz:
https://doaj.org/article/cbd84f3385214d1a91af497c50e13951
Autor:
Sung Yong Han, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Sung Ik Pyeon, Young Joo Park, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho
Publikováno v:
The Korean Journal of Internal Medicine, Vol 36, Iss 3, Pp 544-556 (2021)
Background/Aims Real-world, clinical practice data are lacking about sofosbuvir/ribavirin (SOF/RBV) treatment of Korean patients with hepatitis C virus genotype 2 (HCV GT2) infection. This study investigated the efficacy and safety of SOF/RBV in Kore
Externí odkaz:
https://doaj.org/article/0dd5b4717f3944f68bcf0a17c19e2477